#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Still's disease Glycogen storage disease type V Marfan's syndrome Chronic cutaneous lupus erythematosus Meningitis meningococcal Subdural haematoma Neurodegenerative disorder Philadelphia chromosome positive Arrhythmogenic right ventricular dysplasia Eosinophilic granulomatosis with polyangiitis Leukocyte adhesion deficiency type I Glioblastoma multiforme HER2 gene amplification Hairy cell leukaemia Prolymphocytic leukaemia More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX Epidermolysis bullosa – Treatment Brain stem glioma – Basic Information Haemophilia Alternating hemiplegia of childhood – Diagnostics Marginal zone lymphoma – Basic Information Lymphangioma – Diagnostics Lennox-Gastaut syndrome – Life with Disease Netherton’s syndrome – Trials in Disease Choroid melanoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ertapenem Sodium Imipenem Anhydrate Glycerol Cetrimide Filgrastim At-1501 Feladilimab Tadalafil Pyruvic Acid Belantamab Mafodotin Blood And Related Products Acenocoumarol Bay 2927088 Bi 764532 Vinorelbine Tartrate Concizumab Levoleucovorin Disodium Tigulixostat Nifedipine Bromhexine Hydrochloride More therapies…

    Learn about Your Condition

    Nasal sinus cancer Malformation venous Urticaria chronic Cutaneous calcification Chronic myeloid leukaemia VEXAS syndrome Oesophageal food impaction Noonan syndrome Meniere's disease Haematological malignancy Tachypnoea Femoral hernia Endometrial stromal sarcoma Acquired ATTR amyloidosis Type 1 diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Jagiellońskie Centrum Innowacji Sp. z o.o.

Jagiellońskie Centrum Innowacji Sp. z o.o.

Ul. Profesora Michala Bobrzynskiego 14, Cracow, 30-348, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Azenosertib versus drug combination in platinum‑resistant high‑grade serous ovarian, fallopian tube or primary peritoneal cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Azenosertib
    • Doxorubicin Hydrochloride
    • Gemcitabine Hydrochloride
    Belgium France Germany Ireland Italy Poland +1

  • Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    Finland Germany Greece Hungary Italy Poland +1

  • Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Bulgaria Czechia France Germany Poland

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    • Deucravacitinib
    Germany Hungary Italy Poland Romania Spain

  • Study of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • 2-Amino-6-Fluoro-N-(5-Fluoro-4-(1-Methyl-1H-Imidazol-5-Yl)Pyridin-3-Yl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
    • 8-(1,3-Dimethylpyrazol-4-Yl)-1-(3-Fluoro-5-Methoxypyridin-4-Yl)-7-Methoxy-3-Methylimidazo[4,5-C]Quinolin-2-One
    • Tuvusertib
    Belgium Denmark France Germany Italy The Netherlands +2

  • A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Bulgaria Czechia Germany Poland Spain

  • Study on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Placebo
    Bulgaria Germany Hungary Italy Poland Spain

  • Study on the Safety and Immune Response of mRNA-1345 and mRNA-1365 for Infants with Acute Lower Respiratory Infection Aged 5 to 24 Months

    Not recruiting

    1 1 1
    Investigated Drugs:
    • MRNA-1345
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    Latvia Poland Spain

  • Study on the Safety and Immune Response of MenABCWY Vaccine and Drug Combination in Healthy Infants with Meningococcal Infections

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • GSKVX000000017986
    • HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    Germany Poland Spain

  • Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System for Preventing Pregnancy in Women

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Levonorgestrel
    Czechia Germany Hungary Lithuania Poland Romania +2
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!